Cargando…

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease

BACKGROUND: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25-hydroxy vitamin D (25(OH)D) concentrations than controls. Vitamin D deficiency was associated with increased disease severity and cognitive impairment in prevalent PD patients. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sleeman, Isobel, Aspray, Terry, Lawson, Rachael, Coleman, Shirley, Duncan, Gordon, Khoo, Tien K., Schoenmakers, Inez, Rochester, Lynn, Burn, David, Yarnall, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676984/ https://www.ncbi.nlm.nih.gov/pubmed/28984616 http://dx.doi.org/10.3233/JPD-171122

Ejemplares similares

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease
por: Lord, Sue, et al.
Publicado: (2014)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features
por: Lord, Sue, et al.
Publicado: (2017)

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers
por: Mc Ardle, Ríona, et al.
Publicado: (2022)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
por: Wilson, Joanna, et al.
Publicado: (2020)

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2022)

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
por: Williams‐Gray, Caroline H., et al.
Publicado: (2016)

Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016)

Identifying delirium in Parkinson disease: A pilot study
por: Lawson, Rachael A., et al.
Publicado: (2020)

Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines
por: Christodoulou, Marilena, et al.
Publicado: (2021)

Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
por: Naisby, J., et al.
Publicado: (2021)

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease
por: Mak, Elijah, et al.
Publicado: (2017)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Mak, Elijah, et al.
Publicado: (2015)

Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3)
por: Schoenmakers, Inez, et al.
Publicado: (2013)

Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease
por: Durcan, R., et al.
Publicado: (2019)

Postural Dynamics Are Associated With Cognitive Decline in Parkinson's Disease
por: Pantall, Annette, et al.
Publicado: (2018)

Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead
por: Del Din, Silvia, et al.
Publicado: (2021)

Mobilizing Parkinson’s Disease: The Future of Exercise
por: Ellis, Terry, et al.
Publicado: (2018)

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)
por: Dlay, J. K., et al.
Publicado: (2020)

A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’s
por: Naisby, Jenni, et al.
Publicado: (2021)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

Selecting Clinically Relevant Gait Characteristics for Classification of Early Parkinson’s Disease: A Comprehensive Machine Learning Approach
por: Rehman, Rana Zia Ur, et al.
Publicado: (2019)

Randomized controlled trial of vitamin D supplementation in older people to optimize bone health
por: Aspray, Terry J, et al.
Publicado: (2019)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

Investigating the Impact of Environment and Data Aggregation by Walking Bout Duration on Parkinson’s Disease Classification Using Machine Learning
por: Rehman, Rana Zia Ur, et al.
Publicado: (2022)

Comparison of Walking Protocols and Gait Assessment Systems for Machine Learning-Based Classification of Parkinson’s Disease
por: Rehman, Rana Zia Ur, et al.
Publicado: (2019)

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Nombela, Cristina, et al.
Publicado: (2014)

Vitamin D Supplementation for 12 Months in Older Adults Alters Regulators of Bone Metabolism but Does Not Change Wnt Signaling Pathway Markers
por: Christodoulou, Marilena, et al.
Publicado: (2022)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson’s Disease?
por: Kirk, Cameron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_293m892phnrejdgvdrph66lmpe